Analyst Ratings for Adeptus Biotechnologies Corp. (ADPT) [Sells]
ADPT Rating Summary
ADPT Price Target Summary
- Highest: $14.00 (Piper Sandler)
- Lowest: $5.00 (Goldman Sachs)
- Average: $8.71
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$8.71 (+235.2%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 75%
Avg. $ Target:
$8.71 (+235.2%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 75%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/25/2022 | Credit Suisse | Dan Leonard | New Coverage | Underperform (N/A) |
8.00 (N/A) |
10.75 (2.60) |
-75.81% | Details |
